Learn how Merck used advanced digital modeling strategies for mammalian cell culture in perfusion process in this presentation.
This presentation describes the evolution of the KIWI-biolab at TU Berlin from an automated experimentation platform into a self-driving biolab
Watch how a novel modeling approach combining Elementary Flux Mode column generation with Monod-type kinetics can support smarter bioprocess optimization.
This talk by DataHow's CTO builds the case for what the system requires, from insights and recommendations, through consistent QbD-native methodology and stage-specific workflows.
In this presentation, digital strategies are discussed for building and combining structured data and information to construct knowledge bases, and how high-quality knowledge bases are critical for successfully scaling AI technologies across large enterprises.
This talk explores what needs to happen beyond the pilot: the strategic clarity, leadership sponsorship, data foundations, operating model choices, and execution discipline required to move from experimentation to meaningful impact.
Discover how digital twins represent a transformative tool for biotech and pharma companies, enabling a seamless transition towards Pharma 4.0, rewarded by gaining quality, financial benefit at less time needed for their drug products’ production.
This work introduces a collaborative Bayesian optimization approach that re-integrates human input into the data-driven decision-making process. By combining high-throughput Bayesian optimization with discrete decision theory, experts can influence the selection of experiments via a discrete choice.
This work developed an innovative modeling approach based on combining a propagation hybrid model with a historical data-driven model, that is, the combined hybrid model, for simultaneous prediction of CHO cell culture process dynamics and final product quality.
This presentation explores hybrid modeling methods and their potential to further leverage the generated data for business opportunities.
Discover how Roche created a unified ecosystem that drives smarter, more reliable manufacturing.
This presentation highlights some recent GSK case studies that rely process models, providing context within the evolving regulatory landscape.
See how a hybrid-model was used to characterize and predict the performance of mRNA development steps.